Latest News
|
More Articles...
- Biofourmis Earns FDA’s First-Ever Breakthrough Device Designation for a Novel Digital Therapeutic for Heart Failure
- Blood thinners may prevent cognitive decline in older patients with atrial fibrillation
- Boston Scientific Announces Agreement to Acquire Baylis Medical Company Inc.
- Cardiac Dimensions Included in the New 2021 ESC Guidelines for Heart Failure Management
- Continuous Rhythm Monitoring Reveals Strong Short-Term Risk Association Between Atrial Fibrilation Episodes and Ischemic Stroke
- FDA Alerts Health Care Providers to Stop New Implants of Certain Ventricular Assist Device System
- FDA grants Jardiance® Breakthrough Therapy designation for heart failure with preserved ejection fraction
- Haemonetics Announces VASCADE MVP® Venous Vascular Closure System Gains the First and Only FDA Approval for Same-Day Discharge Following Atrial Fibrillation Ablation
- Heart Tissue in a Dish Reveals New Links Between Neurodegeneration and Heart Disease
- Implicity Launches a Solution to Improve Remote Monitoring of Heart Failure Patients
|
|
